Tech Company Financing Transactions
Logical Therapeutics Funding Round
Logical Therapeutics, based in Foxboro, secured $30 million in investment from SV Health Investors, Burrill & Company and Novitas Capital.
Transaction Overview
Company Name
Announced On
6/13/2007
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series B
Investors
SV Health Investors (Lead Investor) (Lutz Giebel)
Proceeds Purpose
The funding will allow Logical to advance multiple drug candidates,
including its lead drug, LT-NS001, a novel naproxen pro-drug, through
proof- of-concept clinical trials.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
124 Washington St. 101
Foxboro, MA 02035
USA
Foxboro, MA 02035
USA
Phone
Website
Email Address
Overview
The company is developing medicines to treat diseases that are associated with poorly controlled or excessive inflammation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Lutz Giebel
Browse more venture capital transactions:
Prev: 6/12/2007: Telltale venture capital transaction
Next: 6/13/2007: Franklin & Seidelmann Subspecialty Radiology venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs